Benzinga's M&A Chatter for Wednesday July 9, 2014

Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 9, 2014:
Google Rumored to Have Interest in Deal for Time WarnerThe Rumor
:

Shares of Time Warner
TWX
surged higher Tuesday, following a
tweet
from Fox Business' Charlie Gasparino, that he has been hearing chatter of a potential bid from Google
GOOG
. Time Warner shares hit a high of $73.07.
Wall Street Journal
reporter Doug MacMillan later
tweeted
that Time Warner's CEO said his company was not in talks with Google. Time Warner shares closed off the highs Wednesday at $72.41, a gain of more than 2%.
Hearing Potential Bid for GameStopThe Rumor
:

Shares of GameStop
GME
spiked higher Wednesday, on renewed unconfirmed market chatter of a potential bid from an unnamed suitor. Chatter had surfaced on June 22 that GameStop had hired an advisor to help it to review strategic alternatives. A spokesperson for GameStop was unavailable for comment. GameStop shares closed Wednesday at $41.79, a gain of $0.15.
Loading...
Loading...
AbbVie Forced to Retract Comments Regarding Shire Takeover AttemptThe Withdrawn Comments
:

AbbVie
ABBV
CEO Richard Gonzalez was forced to withdraw comments he made regarding shareholder support for his company's bid for Shire
SHPG
. The comments were a violation of UK Takeover Panel rules, as the support was not in writing. AbbVie confirmed today, it had not received commitments of support in writing. Shire closed Wednesday at $235.08, a gain of almost 1%, while AbbVie lost more than 1% to close at $55.01.
Shareholders Urge Allergan to Make AcquisitionsThe CEO Comments
:

Allergan
AGN
shareholders are encouraging the company to make a large acquisition in order to fight off a $53 billion hostile takeover bid from Valeant Pharmaceuticals
VRX
and investor Bill Ackman of Pershing Square, according to a report from
Financial Times
. Allergan CEO David Pyott, said his company should act quickly in making an acquisition, based on comments from shareholders. Allergan's board rejected Valeant's latest bid of $53 billion in cash and Valeant shares on June 23. Allergan closed Wednesday at $165.20, a loss of $0.87, while Valeant lost 1% to close at $120.94.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsRumorsHedge FundsMovers & ShakersManagementInsider TradesMoversGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...